# Zhang Ye

> Zhang Ye is a Series A investor at BioTrack Capital backing Biotechnology and Pharmaceutical. See 1 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [BioTrack Capital](https://shizune.co/investors/profile/biotrack-capital)
- Total investments: 1
- Last investment: Apr 2026
- Lead investor: 0%
- Last updated: Aug 2026

Zhang Ye is a Series A investor at BioTrack Capital focused on Biotechnology and Pharmaceutical. Zhang Ye is the Project Manager of Boyuan Capital.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 1 | 100% |
| Pharmaceutical | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Aureka Biotechnologies | Aureka Biotechnologies is a pioneering biotech firm dedicated to democratizing the pharmaceutical sector in order to conquer sickness. | $35M | Series A | Apr 28, 2026 |  |

1 of 1 investments shown.

## Co-investors
- [Matrix Partners China](https://shizune.co/investors/profile/matrix-partners-china) — VC Fund, 1 deal together
- [5Y Capital](https://shizune.co/investors/profile/morningsidevc) — VC Fund, 1 deal together
- [Newlife Capital](https://shizune.co/investors/profile/newlife-capital) — VC Fund, 1 deal together
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund, 1 deal together
- [HongShan](https://shizune.co/investors/profile/sequoia-china) — VC Fund, 1 deal together

## About BioTrack Capital

VC Fund · Shanghai, China

BioTrack Capital invests in early and growth stage companies within life sciences, healthcare technology, biotechnology and related high-tech sectors, providing capital and investment support for innovation. The firm evaluates scientific and commercial potential of ventures and structures financings aimed at advancing technologies from earlyresearch to market engagement. Its activities include sourcing opportunities, conducting due diligence, and working with founders and management teams to align growth strategies with investor objectives. BioTrack Capital also participates in funding rounds alongside co-investors to support development of novel healthcare and tech solutions. The company engages with portfolio companies through strategic interaction and monitoring of progress toward business milestones.

4 contacts available at BioTrack Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Feng Tao | Co-Founder & Partner | https://shizune.co/investors/profile/feng-tao-481b |
| Jiacong Guo | Executive Director | https://shizune.co/investors/profile/jiacong-guo |
| Kevin (Penghui) Chen | Founder & Partner | https://shizune.co/investors/profile/kevin-penghui-chen |
| Zhang Ye | Project Manager | https://shizune.co/investors/profile/zhang-ye-1d05 |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Zhang Ye invest in?

Zhang Ye invests primarily in Biotechnology and Pharmaceutical startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Zhang Ye last invest?

The most recent investment recorded for Zhang Ye closed in Apr 2026. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co